Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation

Bone Marrow Transplantation

Volumn 28, Issue 2, 2001, Pages 157-161

  Kreiter, S ^a   Winkelmann, N ^a   Schneider, P M ^b   Schuler, M ^a   Fischer, T ^a   Ullmann, A J ^a   Huber, C ^a   Derigs, H G ^a   Kolbe, K ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Allogeneic stem cell transplantation; Chimerism analysis; Fludarabine; Multiple myeloma; Non myeloablative; T cell depletion

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGRAFT; ARTICLE; BONE MARROW; CANCER REGRESSION; CELL PROLIFERATION; CHEDIAK HIGASHI SYNDROME; CHIMERA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DEATH; DISEASE SEVERITY; DONOR; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; INCIDENCE; LYMPHOCYTE TRANSFUSION; MALE; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RADIATION DOSE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TIME; TOXICITY; WHOLE BODY RADIATION;

ADULT; CHEDIAK-HIGASHI SYNDROME; CYCLOSPORINE; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYCOPHENOLIC ACID; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 0034898702     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703107     Document Type: Article

References (16)

1. Mini-allografts: Ongoing trials in humans
2. Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia
3. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant
4. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation
5. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation
6. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versushost disease among lethally irradiated dogs given DLA-non-identical unrelated marrow grafts
7. In vivo CAM-PATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
8. Graft-versus-leukemia reactions after bone marrow transplantation
9. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow
10. Bone marrow engraftment analysis after allogeneic bone marrow transplantation
11. Chediak-Higashi syndrome: Approaches in diagnosis and treatment
12. CD34 selected alloPBSCT and adoptive immunotherapy
13. Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: A therapeutic strategy
14. Short report: Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen
15. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation
16. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses